Dear Colleague,
Increasing generic challenge, harder to come by drug approvals,
potential Patent Reform and subsequent Supreme Court & Federal
Circuit rulings all make the job of protecting and enforcing
intellectual property increasingly complex.
In addition, with patents expiring and feverish product development to
bolster drug pipelines, senior management is expecting the IP function
to do more than just file and litigate.
After all, IP is more than just filing patents, isn’t it?
Intellectual property is more than defending inventions – it is businesscritical.
With a perfect storm brewing caused by potential reforms and
recent Supreme Court and Federal circuit rulings you will need to
quickly adapt to stay ahead of your competitors. Attend
PharmaBiotech IP to gain insight into how best to:
- Effectively navigate the waters and adapt your strategies to
ensure long term protection and enforcement of your patents
- Adapt your prosecution and enforcement strategies to protect
products coming on line and strategically manage your portfolio to get the best out of it, extending the useful life cycle of
commercially valuable assets
- Truly align IP with the business and cement the fact that the IP
function can be a resource and not a roadblock to become a
true partner of the business
If you are an IP professional in the pharma/biotech industry this is the
industry event of the year!
Looking forward to seeing you in Philadelphia!
Best Regards,
|
|
© 2007 WBR. All rights reserved. 
